These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7940873)

  • 1. Pediatric liver transplantation: delay in initiation of cyclosporine therapy beyond the immediate postoperative period does not adversely affect outcome.
    Lynch SV; Yamanaka J; Balderson GA; McEniery JA; Delbridge RG; Ong TH; Pillay SP; Strong RW
    Transplant Proc; 1994 Oct; 26(5):2771-4. PubMed ID: 7940873
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimal clinical regimens for living related liver transplantation.
    Malagó M; Rogiers X; Wadström J; Burdelski M; Broelsch CE
    Transplant Proc; 1994 Oct; 26(5):2665-8. PubMed ID: 7940834
    [No Abstract]   [Full Text] [Related]  

  • 3. Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxis.
    Lemmens HP; Langrehr JM; Blumhardt G; Lohmann R; Knoop M; Verschl J; Schattenfroh N; Neuhaus R; Hopf U; Bechstein WO
    Transplant Proc; 1994 Dec; 26(6):3622-3. PubMed ID: 7527983
    [No Abstract]   [Full Text] [Related]  

  • 4. Short- and long-term cyclosporine dosage in liver transplantation.
    McCaughan GW; Bookallil MJ; Sheil AG
    Transplant Proc; 1994 Oct; 26(5):2674-5. PubMed ID: 7940837
    [No Abstract]   [Full Text] [Related]  

  • 5. Improved success of pediatric renal transplantation.
    Seki T; Takeuchi I; Tanda K; Chikaraishi T; Kanagawa K; Nonomura K; Togashi M; Koyanagi T
    Transplant Proc; 1994 Aug; 26(4):2067-8. PubMed ID: 8066672
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimal immunosuppressive clinical regimen in liver transplantation.
    Farges O; Samuel D; Bismuth H
    Transplant Proc; 1994 Oct; 26(5):2676-8. PubMed ID: 7940838
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence and outcome of OKT3 treatment for early steroid-resistant rejection following hepatic transplantation.
    Lange D; Bechstein WO; Blumhardt G; Lemmens P; Schattenfroh N; Neuhaus P
    Transplant Proc; 1993 Apr; 25(2):1870-1. PubMed ID: 8470207
    [No Abstract]   [Full Text] [Related]  

  • 8. [Value of a powerful initial immunosuppression after liver transplantation. Prospective study of 60 cases].
    Cherqui D; Duvoux C; Charlotte F; Humeres R; Lauzet JY; Métreau JM; Salvat A; Rotman N; Julien M; Fagniez PL
    Gastroenterol Clin Biol; 1994; 18(2):115-22. PubMed ID: 8013792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine A monitoring in liver transplant.
    Tisone G; Vennarecci G; Pisani F; Pieragostini E; Alciati E; Casciani CU
    Transplant Proc; 1994 Oct; 26(5):2691-2. PubMed ID: 7940842
    [No Abstract]   [Full Text] [Related]  

  • 10. Intensive care after orthotopic liver transplantation.
    Sun CK; Chen CL; Kuo YC; Chen YS
    Transplant Proc; 1994 Aug; 26(4):2246-7. PubMed ID: 7520627
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction therapy with anti-T-lymphocyte globulin following orthotopic liver transplantation.
    Schattenfroh N; Lange D; Bechstein WO; Blumhardt G; Keck H; Langrehr JM; Lohmann R; Neuhaus P
    Transplant Proc; 1993 Aug; 25(4):2702. PubMed ID: 8356722
    [No Abstract]   [Full Text] [Related]  

  • 12. Quadruple-drug therapy with antithymocyte globulin in the early postoperative period after liver transplantation.
    Schattenfroh N; Lange D; Bechstein WO; Blumhardt G; Lohmann R; Neuhaus P
    Transplant Proc; 1993 Apr; 25(2):1968-9. PubMed ID: 8470245
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients.
    Platz KP; Tullius SG; Mueller AR; Schumacher G; Nüssler N; Neuhaus R; Bechstein WO; Lobeck H; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3183-4. PubMed ID: 8962235
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic rejection in pediatric liver transplantation.
    Cho JH; Bhatnagar V; Andreani P; Muiesan P; Portmann B; Baker A; Mieli-Vergani G; Gibbs P; Rela M; Heaton ND
    Transplant Proc; 1997; 29(1-2):452-3. PubMed ID: 9123078
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporine kinetics in pediatric liver transplant recipients: impact of dose fractionation on true glomerular filtration rate.
    Paradis K; al Edreesi M; St-Vil D; Laberge JM; Dupuis C; Rasquin-Weber A
    Transplant Proc; 1994 Oct; 26(5):2777-8. PubMed ID: 7940875
    [No Abstract]   [Full Text] [Related]  

  • 16. Conversion from Sandimmune to Neoral in stable liver graft recipients.
    Pollard SG; Lodge JP
    Transplant Proc; 1996 Aug; 28(4):2244-6. PubMed ID: 8769213
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclosporine levels in the early posttransplant period: predictive of chronic rejection in liver transplantation?
    Soin AS; Rasmussen A; Jamieson NV; Tokat Y; Watson CJ; Friend PJ; Wight DG; Calne RY
    Transplant Proc; 1995 Feb; 27(1):1129-30. PubMed ID: 7878821
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal allograft function and histology in children on triple immunosuppression based on individual pharmacokinetically determined cyclosporine administration.
    Laine J; Hoppu K; Holmberg C
    Transplant Proc; 1994 Oct; 26(5):2775-6. PubMed ID: 7940874
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of calcineurin inhibitors in pediatric liver transplantation: a single-center experience.
    Taylor RM; Cheeseman P; Rela M; Heaton N; Mieli-Vergani G; Dhawan A
    Transplant Proc; 2002 Aug; 34(5):1974-5. PubMed ID: 12176652
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporine A withdrawal during follow-up after pediatric liver transplantation.
    Scheenstra R; Torringa ML; Waalkens HJ; Middelveld EH; Peeters PM; Slooff MJ; Gouw AS; Verkade HJ; Bijleveld CM
    Liver Transpl; 2006 Feb; 12(2):240-6. PubMed ID: 16447209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.